NCT06084468Active, not recruiting
Cardiac Structure and Function in Patients with Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 13 Mar 2025
Brief summary (registry, in English)
In a prospective observational cohort study (n = 100), the investigators aim to assess the correlation between cardiac biomarkers, advanced echocardiography and cystic fibrosis genotype and severity and determine whether these are prognostic markers of heart disease in patients suffering from cystic fibrosis (CF).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 104 (actual)
- First submitted
- 10 Oct 2023
- Start date
- 1 Jan 2023
- Primary completion date
- 1 Mar 2023
- Lead sponsor
- Herlev and Gentofte Hospital
- NCT number
- NCT06084468
What you commit to
- Study type: Observational
- Participants enrolled: 104
- From 1 Jan 2023 to the primary completion date, 1 Mar 2023
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior lung transplant
Other
- Inability to cooperate
- Inability to understand and sign informed consent
Who the study is looking for
- CF diagnosis
- Age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Infectious Diseases, University Hospital of Copenhagen, Cystic Fibrosis Centre, Copenhagen, Denmark Coordinator of this site? Confirm its status | Copenhagen | Denmark | Unknown status |
| Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen Coordinator of this site? Confirm its status | Hellerup | Denmark | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.